Summit Therapeutics Inc.
Manmeet Singh Soni (COO and CFO) reports SMMT insider transactions
About this filing
Summit Therapeutics Inc. (SMMT) filed Form 4 (insider transaction) with the SEC on Nov 16, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Manmeet Singh Soni · COO and CFO, Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | M · exercise or conversion of a derivativeFootnotes F1, F2 | +100,000 | $1.37 | $137,000.00 | 3,224,375 | Direct |
| Nov 16, 2026 | M · exercise or conversion of a derivativeStock Option (right to buy)Footnotes F1, F3 | −100,000 | $0.00 | $0.00 | 100,000 | Direct |
Footnotes
- F1 On November 16, 2026, the Reporting Person exercised an option to purchase 100,000 shares of the Issuer's common stock at an exercise price of $1.37 per share.
- F2 Holdings include shares previously acquired through exempt transactions pursuant to the Issuer's employee stock purchase plan.
- F3 The option was granted on December 23, 2019. The shares underlying the option vested in four equal annual installments, with the first such installment beginning on December 23, 2020.
More SMMT filings
- 8-K
Filed Nov 18, 2026
- 4
Filed Nov 16, 2026
- 4
Filed Nov 16, 2026
- 8-K
Filed Nov 16, 2026
- 8-K
Filed Nov 4, 2026
- 424B7
Filed Nov 4, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.